BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37680741)

  • 1. Therapeutic strategies for asymptomatic upper urinary tract urothelial carcinoma.
    Lin D; Hong Y; Yang Z; Ye L
    Wideochir Inne Tech Maloinwazyjne; 2023 Jun; 18(2):343-350. PubMed ID: 37680741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Surgical Wait Time on Survival in Patients With Upper Urinary Tract Urothelial Carcinoma With Hydronephrosis.
    Zhao F; Qi N; Zhang C; Xue N; Li S; Zhou R; Chen Z; Yao R; Zhu H
    Front Oncol; 2021; 11():698594. PubMed ID: 34290988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinoma.
    Simon CT; Skala SL; Weizer AZ; Ambani SN; Chinnaiyan AM; Palapattu G; Hafez K; Magers MJ; Kaffenberger SD; Spratt DE; Montgomery JS; Morgan TM; Udager AM; Lew M; Mehra R
    Hum Pathol; 2019 Apr; 86():76-84. PubMed ID: 30537495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinicopathological features in metastatic upper tract urothelial carcinoma and urothelial bladder cancer.
    Xie J; Zhang XB; Wen J; Zhang YS; Li HZ
    Int Urol Nephrol; 2016 Apr; 48(4):481-7. PubMed ID: 26797856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic Management of Upper Urinary Tract Urothelial Carcinoma: Oncologic Outcomes and Prognostic Factors in a Contemporary Cohort.
    Sanguedolce F; Fontana M; Turco M; Territo A; Lucena JB; Cortez JC; Vanacore D; Meneghetti I; Gallioli A; Gaya JM; Redorta JP; Breda A
    J Endourol; 2021 Nov; 35(11):1593-1600. PubMed ID: 33971725
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence, characteristics, treatment strategies, and oncologic outcomes of synchronous bilateral upper tract urothelial carcinoma in the Chinese population.
    Fang D; Xiong G; Li X; Kang Y; Zhang L; Zhao G; Chen X; Yao L; Zhang X; Yu W; Gong K; Song Y; He Q; He Z; Zhou L; Guo Y
    Urol Oncol; 2015 Feb; 33(2):66.e1-11. PubMed ID: 25240760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
    Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of the initial clinical presentation of upper tract urothelial carcinoma on histopathological tumor features.
    Jakus D; Šolić I; Borovac JA; Šitum M
    Int Urol Nephrol; 2024 Apr; 56(4):1335-1341. PubMed ID: 38015383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aristolochic acid-associated urinary tract cancers: an updated meta-analysis of risk and oncologic outcomes after surgery and systematic review of molecular alterations observed in human studies.
    Kang YC; Chen MH; Lin CY; Lin CY; Chen YT
    Ther Adv Drug Saf; 2021; 12():2042098621997727. PubMed ID: 33815744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer.
    Bree KK; Hensley PJ; Brooks NA; Matulay J; Li R; Nogueras Gonzalez GM; Navai N; Grossman HB; Matin SF; Dinney CPN; Kamat AM
    BJU Int; 2021 Nov; 128(5):568-574. PubMed ID: 33484074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples.
    Pierconti F; Martini M; Fiorentino V; Cenci T; Racioppi M; Foschi N; Di Gianfrancesco L; Sacco E; Rossi E; Larocca LM; Bassi PF
    Hum Pathol; 2021 Dec; 118():42-48. PubMed ID: 34582934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Gontero P; Van Rhijn BWG; Mostafid AH; Palou J; Shariat SF
    Eur Urol; 2018 Jan; 73(1):111-122. PubMed ID: 28867446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
    Rink M; Ehdaie B; Cha EK; Green DA; Karakiewicz PI; Babjuk M; Margulis V; Raman JD; Svatek RS; Fajkovic H; Lee RK; Novara G; Hansen J; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Fisch M; Scherr DS; Shariat SF; ;
    Eur Urol; 2012 Oct; 62(4):677-84. PubMed ID: 22349570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the Bladder.
    Yang K; Yu W; Liu H; Ding F; Zhang Y; Zhang Y; Wang W; Lou F; Cao S; Wang H; He Z
    Oncologist; 2021 Aug; 26(8):e1395-e1405. PubMed ID: 34050578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Location Based Segmentation in Upper-Tract Urothelial Carcinoma Impacts on the Urothelial Recurrence-Free Survival: A Multi-Institutional Database Study.
    Inamoto T; Matsuyama H; Komura K; Ibuki N; Fujimoto K; Shiina H; Sakano S; Nagao K; Mastumoto H; Miyake M; Tatsumi Y; Yasumoto H; Azuma H
    Curr Urol; 2020 Dec; 14(4):183-190. PubMed ID: 33488336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy and Clinical Utility of a Tumor Grade- and Stage-based Predictive Model in Localized Upper Tract Urothelial Carcinoma.
    Katayama S; Mori K; Schuettfort VM; Pradere B; Mostafaei H; Quhal F; Rajwa P; Motlagh RS; Laukhtina E; Moschini M; Grossmann NC; Araki M; Teoh JY; Rouprêt M; Margulis V; Enikeev D; Karakiewicz PI; Abufaraj M; Compérat E; Nasu Y; Shariat SF
    Eur Urol Focus; 2022 May; 8(3):761-768. PubMed ID: 34053904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-operative urothelial recurrence in patients with upper urinary tract urothelial carcinoma managed by radical nephroureterectomy with an ipsilateral bladder cuff: Minimal prognostic impact in comparison with non-urothelial recurrence and other clinical indicators.
    Takahara K; Inamoto T; Komura K; Watsuji T; Azuma H
    Oncol Lett; 2013 Oct; 6(4):1015-1020. PubMed ID: 24137456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
    Lee YE; Chan TC; Tian YF; Liang PI; Shiue YL; Chen YS; He HL
    Urol Oncol; 2019 May; 37(5):299.e7-299.e18. PubMed ID: 30660494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.